Market Research Logo

Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging

Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging

The global market for contract pharmaceutical manufacturing, research and packaging totaled $248.5 billion in 2014 and is projected to approach $352.8 billion by 2019, registering a compound annual growth rate (CAGR) of 7.3% through 2019.

This report provides:

An overview of the global market for contract pharmaceutical manufacturing, research, and packaging, with emphasis on the current and future outlook of the market and a comprehensive analysis of the overall pharmaceutical and biotechnology outsourcing industry.

Analyses of global market trends, with data from 2013 and 2014, and projections of compound annual growth rates (CAGRs) through 2019.

Examination of the effects on market growth of state-of-the-art packaging facilities as well as expensive research facilities and the capabilities of research organizations.

Coverage of the market's need for outsourcing, the regulatory environment, and technological issues, including the latest trends and developments.

Comprehensive company profiles of major players.


SCOPE OF REPORT

The scope of this study covers in-depth analysis of the global contract manufacturing, research and packaging markets. The contract manufacturing market for the pharmaceutical industry is segmented into various dosage forms, over-the-counter (OTC) and nutraceuticals, and drug delivery technologies. Clinical, drug discovery, analytical and other segments of pharmaceutical research through outsourcing have been analyzed under the contract research market. The contract packaging market is segmented into primary, secondary and tertiary packaging. In the primary packaging market, primary containers are categorized as blisters, bottles and a large category of “others,” which includes prefillable syringes, inhalers, vials and ampoules, caps and closures, dosing droppers, and labels and accessories. Analysis of market segments, trends and revenue forecasts for the global, North American and European regions as well as emerging markets have been provided in detail. The emerging market for contract manufacturing includes countries such as India, China, Japan, Korea, Taiwan, Canada, Africa, Australia, New Zealand, etc. BCC Research analyzes each market by its application, its regulatory environment and its technology. This analysis includes market projections and estimating market shares of the players.

CHAPTER 1 INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
INTENDED AUDIENCE
SCOPE OF REPORT
METHODOLOGY AND INFORMATION SOURCES
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 EXECUTIVE SUMMARY
SUMMARY TABLE GLOBAL MARKET FOR CONTRACT PHARMACEUTICAL MANUFACTURING, RESEARCH AND PACKAGING BY SEGMENT, THROUGH 2019 ($ BILLIONS)
SUMMARY FIGURE GLOBAL MARKET FOR CONTRACT PHARMACEUTICAL MANUFACTURING, RESEARCH AND PACKAGING BY SEGMENT, 2012-2019 ($ BILLIONS)
CHAPTER 3 OVERVIEW
OUTSOURCING
HISTORY OF OUTSOURCING
TABLE 1 KEY DEVELOPMENTS IN THE HISTORY OF OUTSOURCING
KEY COMPONENTS OF A SUCCESSFUL OUTSOURCING STRATEGY
CORE FUNCTIONAL AREAS THAT NEED CONSTANT MONITORING
Cost Management
Communication Management
Performance Management
Risk Management
Crisis Management
Knowledge Transfer Management
Relationship Management
CONTRACT MANUFACTURING
TYPES OF CONTRACT MANUFACTURERS
Those Who "Supply"
Those Who "Toll"
Types of Toll Manufacturers
Sellers of Excess Capacity
Suitable Service Providers
Academic Institutions
FOUR STAGES OF CONTRACT MANUFACTURING
Program Initiation
Service Implementation
Final Agreement
Program Closure
CORE CAPABILITIES OF CMOs
REASONS FOR PHARMACEUTICAL CONTRACT MANUFACTURING
Reduce and Control Operating Costs
Focus on Core Competencies
Access to Advanced Technologies
Risk Sharing
BENEFITS OF CONTRACT MANUFACTURING
SUCCESS FACTORS IN CONTRACT MANUFACTURING
Product Quality
Cost-Competitiveness
Delivery Schedule
CM/Customer Relationship
RISKS IN CONTRACT MANUFACTURING
Lack of Control
Relationships
Quality Concerns
Intellectual Property Loss
Other Risks
Capacity Constraints
Loss of Flexibility and Responsiveness
TABLE 2 ADVANTAGES AND DISADVANTAGES OF CONTRACT
MANUFACTURING
SYSTEMIC APPROACH FOR SELECTING A CONTRACT MANUFACTURER
Getting the List
Make a List
Contact CMOs and Create Request for Quote Package
Site Visit
Negotiation with the Finalists
CONTRACT RESEARCH ORGANIZATIONS
SERVICES OFFERED BY A CRO
BENEFITS OF USING A CRO
SELECTING A CRO
CLIENT-CRO RELATIONSHIP
KEYS FOR A SUCCESSFUL CLIENT-CRO RELATIONSHIP
Selecting the Right Partner
Avoiding Unclear Expectations and Vague or Conflicting Requirements
Avoiding Micro-managing Every Step
Setting Realistic Expectations
Vendor's Input
Expecting a CRO to Replicate Client’s Processes
Promising Based on Capabilities
Understanding the Project's Goals
Managing Communications
Problem-solving Aptitude
CONTRACT PACKAGING
TYPES OF PACKAGING
Primary Packaging
Secondary Packaging
Tertiary Packaging
REASONS A CONTRACT PACKAGER MIGHT BE NEEDED
CHOOSING A CONTRACT PACKAGER
Location
Relevant Experience
Ethics
Cost
Communication
Controls
Quality
ETHICAL STANDARDS FOR CONTRACT PACKAGERS
CHAPTER 4 REGULATORY ASPECTS
WARNING LETTERS
TABLE 3 PHARMACEUTICAL MANUFACTURERS THAT RECEIVED WARNING LETTERS, 2014
TABLE 4 PHARMACEUTICAL MANUFACTURERS THAT RECEIVED WARNING LETTERS, 2013
TABLE 5 PHARMACEUTICAL MANUFACTURERS THAT RECEIVED WARNING LETTERS, 2012
TABLE 6 PHARMACEUTICAL MANUFACTURERS THAT RECEIVED WARNING LETTERS, 2011
REGULATORY APPROVALS
TABLE 7 REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, 2014
TABLE 8 REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, 2013
TABLE 9 REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, 2012
TABLE 10 REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, 2011
CHAPTER 5 NEW DEVELOPMENTS
ACTAVIS PLC
LONZA
BRISTOL-MYERS SQUIBB
ABBVIE
ALBANY MOLECULAR RESEARCH INC.
BASF
EVOTEC AG
HOSPIRA
MALLINCKRODT
DR. REDDY'S LABORATORIES
PERRIGO CO. PLC
PATHEON
OTHER
CHAPTER 6 MARKET ANALYSIS: CONTRACT MANUFACTURING
CONTRACT MANUFACTURING OF BULK DRUGS/APIs
MARKET OVERVIEW
MARKET REVENUE
TABLE 11 GLOBAL REVENUE FOR BULK DRUG/APIs THROUGH CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 1 GLOBAL REVENUE FOR BULK DRUG/APIs THROUGH CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS)
CONTRACT MANUFACTURE OF DOSAGE FORMS
MARKET BY TYPE
Market Overview
Market Revenue
TABLE 12 GLOBAL REVENUE FOR CONTRACT MANUFACTURING OF VARIOUS DOSAGE FORMS, THROUGH 2019 ($ MILLIONS)
FIGURE 2 GLOBAL REVENUE FOR CONTRACT MANUFACTURING OF VARIOUS DOSAGE FORMS, 2012-2019 ($ MILLIONS)
MARKET BY REGION
Solid Dosage Form
Market Overview
Market Revenue
TABLE 13 GLOBAL REVENUE FOR SOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 3 GLOBAL REVENUE FOR SOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS)
Liquid Dosage Forms
Market Overview
Non-sterile Formulations
Sterile Formulations
Market Revenue for Non-sterile Formulations
TABLE 14 GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (NON-STERILE) THROUGH CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 4 GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (NON-STERILE) THROUGH CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS)
Market Revenue for Sterile Formulations
TABLE 15 GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (STERILE) THROUGH CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 5 GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (STERILE) THROUGH CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS)
Semisolid Dosage Forms
Market Overview
Market Revenue
TABLE 16 GLOBAL REVENUE FOR SEMISOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 6 GLOBAL REVENUE FOR SEMISOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS)
MARKET BY FORMULATIONS
Solid Dosage Forms
Market Revenue for Solid Dosage Forms
TABLE 17 GLOBAL REVENUE FOR SOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, THROUGH 2019 ($ MILLIONS)
FIGURE 7 GLOBAL REVENUE FOR SOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2012-2019 ($ MILLIONS)
Market Share of Solid Dosage Formulations
TABLE 18 GLOBAL MARKET SHARE OF SOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
FIGURE 8 GLOBAL MARKET SHARE OF SOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
Liquid Dosage Forms
Market Revenue of Non-sterile Forms
TABLE 19 GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (NON-STERILE) THROUGH CONTRACT MANUFACTURING BY FORMULATION, THROUGH 2019 ($ MILLIONS)
FIGURE 9 GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (NON-STERILE) THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2012-2019 ($ MILLIONS)
Market Share of Non-sterile Formulations
TABLE 20 GLOBAL MARKET SHARE OF LIQUID DOSAGE FORMS (NON-STERILE) THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
FIGURE 10 GLOBAL MARKET SHARE OF LIQUID DOSAGE FORMS (NON-STERILE) THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
Market Revenue for Sterile Formulations
TABLE 21 GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (STERILE)
THROUGH CONTRACT MANUFACTURING BY FORMULATION, THROUGH 2019 ($ MILLIONS)
FIGURE 11 GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (STERILE) THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2012-2019 ($ MILLIONS)
Market Share of Sterile Formulations
TABLE 22 GLOBAL MARKET SHARE OF LIQUID DOSAGE FORMS (STERILE) THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
FIGURE 12 GLOBAL MARKET SHARE OF LIQUID DOSAGE FORMS (STERILE) THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
Semisolid Dosage Forms
Market Revenue
TABLE 23 GLOBAL REVENUE FOR SEMISOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, THROUGH 2019 ($ MILLIONS)
FIGURE 13 GLOBAL REVENUE FOR SEMISOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2012-2019 ($ MILLIONS)
Market Share
TABLE 24 GLOBAL MARKET SHARE OF SEMISOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
FIGURE 14 GLOBAL MARKET SHARE OF SEMISOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
ADVANCED DRUG DELIVERY PRODUCTS THROUGH CONTRACT
MANUFACTURING
MARKET OVERVIEW
TABLE 25 SOME CONTRACTING COMPANIES PROVIDING DRUG-DELIVERY
SYSTEMS
MARKET BY REGION
TABLE 26 GLOBAL REVENUE FOR ADVANCED DRUG DELIVERY SYSTEMS THROUGH CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 15 GLOBAL REVENUE FOR ADVANCED DRUG DELIVERY SYSTEMS THROUGH CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS)
MARKET BY FORMULATION
TABLE 27 GLOBAL REVENUE FOR ADVANCED DRUG DELIVERY SYSTEMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, THROUGH 2019 ($ MILLIONS)
FIGURE 16 GLOBAL REVENUE FOR ADVANCED DRUG DELIVERY SYSTEMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2012-2019 ($ MILLIONS)
MARKET SHARE
TABLE 28 GLOBAL MARKET SHARE OF ADVANCED DRUG DELIVERY SYSTEMS THROUGH CONTRACT MANUFACTURING BY TYPE, 2013 (%)
FIGURE 17 GLOBAL MARKET SHARE OF ADVANCED DRUG DELIVERY SYSTEMS THROUGH CONTRACT MANUFACTURING BY TYPE, 2013 (%)
CONTRACT MANUFACTURE OF OTC AND NUTRACEUTICALS
MARKET BY REGION
Market Revenue
TABLE 29 GLOBAL REVENUE FOR OTC AND NUTRACEUTICALS THROUGH CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ BILLIONS)
FIGURE 18 GLOBAL REVENUE FOR OTC AND NUTRACEUTICALS THROUGH CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ BILLIONS)
MARKET BY FORMULATION
TABLE 30 GLOBAL REVENUE FOR OTC AND NUTRACEUTICALS THROUGH CONTRACT MANUFACTURING BY FORMULATION, THROUGH 2019 ($ BILLIONS)
FIGURE 19 GLOBAL REVENUE FOR OTC AND NUTRACEUTICALS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2012-2019 ($ BILLIONS)
Market Share
TABLE 31 GLOBAL MARKET SHARE OF OTC AND NUTRACEUTICALS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
FIGURE 20 GLOBAL MARKET SHARE OF OTC AND NUTRACEUTICALS THROUGH CONTRACT MANUFACTURING BY DOSAGE TYPE, 2013 (%)
CONTRACT MANUFACTURING OF BULK DRUGS AND DOSAGE FORMS BY APPLICATION/THERAPEUTIC AREA
CARDIOVASCULARS
ANTIBIOTICS
ANALGESICS
ONCOLOGY
ANTIVIRALS
REPRODUCTIVE DRUG PRODUCTS
OTHER DRUGS
MARKET REVENUE
TABLE 32 GLOBAL REVENUE FOR CONTRACT MANUFACTURING DRUGS BY THERAPEUTIC CATEGORY, THROUGH 2019 ($ MILLIONS)
FIGURE 21 GLOBAL REVENUE FOR CONTRACT MANUFACTURING DRUGS BY THERAPEUTIC CATEGORY, 2012-2019 ($ MILLIONS)
MARKET SHARE
TABLE 33 GLOBAL MARKET SHARE OF VARIOUS THERAPEUTIC CATEGORIES IN CONTRACT MANUFACTURING, 2013 (%)
FIGURE 22 GLOBAL MARKET SHARE OF VARIOUS THERAPEUTIC CATEGORIES IN CONTRACT MANUFACTURING, 2013 (%)
CHAPTER 7 MARKET ANALYSIS: CONTRACT RESEARCH
MARKET BY DISCIPLINE
MARKET OVERVIEW
MARKET REVENUE
TABLE 34 GLOBAL REVENUE FOR CONTRACT RESEARCH BY DISCIPLINE, THROUGH 2019 ($ MILLIONS)
FIGURE 23 GLOBAL REVENUE FOR CONTRACT RESEARCH BY DISCIPLINE, 2012-2019 ($ MILLIONS)
MARKET SHARE
TABLE 35 GLOBAL MARKET SHARE OF CONTRACT RESEARCH BY DISCIPLINE, 2013 (%)
FIGURE 24 GLOBAL MARKET SHARE OF CONTRACT RESEARCH BY DISCIPLINE, 2013 (%)
MARKET BY REGION
MARKET OVERVIEW
MARKET REVENUE
TABLE 36 GLOBAL REVENUE FOR CONTRACT RESEARCH BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 25 GLOBAL REVENUE FOR CONTRACT RESEARCH MARKET BY REGION, 2012-2019 ($ MILLIONS)
MARKET SHARE
TABLE 37 GLOBAL MARKET SHARE OF CONTRACT RESEARCH BY REGION, 2013 (%)
FIGURE 26 GLOBAL MARKET SHARE OF CONTRACT RESEARCH MARKET BY REGION, 2013 (%)
CONTRACT CLINICAL RESEARCH MARKET BY REGION
TABLE 38 GLOBAL REVENUE FOR CONTRACT CLINICAL RESEARCH BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 27 GLOBAL REVENUE FOR CONTRACT CLINICAL RESEARCH BY REGION, 2012-2019 ($ MILLIONS)
CONTRACT DRUG DISCOVERY MARKET BY REGION
TABLE 39 GLOBAL REVENUE FOR CONTRACT DRUG DISCOVERY BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 28 GLOBAL REVENUE FOR CONTRACT DRUG DISCOVERY BY REGION, 2012-2019 ($ MILLIONS)
CONTRACT ANALYTICAL RESEARCH MARKET BY REGION
TABLE 40 GLOBAL REVENUE FOR CONTRACT ANALYTICAL RESEARCH MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 29 GLOBAL REVENUE FOR CONTRACT ANALYTICAL RESEARCH MARKET BY REGION, 2012-2019 ($ MILLIONS)
OTHER CONTRACT RESEARCH ACTIVITIES MARKET BY REGION
TABLE 41 GLOBAL REVENUE FOR OTHER CONTRACT RESEARCH MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 30 GLOBAL REVENUE FOR OTHER CONTRACT RESEARCH MARKET BY REGION, 2012-2019 ($ MILLIONS)
MARKET BY THERAPEUTIC AREA
CARDIOLOGY
ONCOLOGY
INFLAMMATION AND IMMUNOLOGY
NEUROSCIENCE
VACCINES
OTHERS
MARKET REVENUE
TABLE 42 GLOBAL REVENUE FOR CONTRACT RESEARCH BY THERAPEUTIC AREA, THROUGH 2019 ($ MILLIONS)
FIGURE 31 GLOBAL REVENUE FOR CONTRACT RESEARCH BY THERAPEUTIC AREA, 2012-2019 ($ MILLIONS)
MARKET SHARE
TABLE 43 GLOBAL MARKET SHARE OF CONTRACT RESEARCH BY THERAPEUTIC AREA, 2013 (%)
FIGURE 32 GLOBAL MARKET SHARE OF CONTRACT RESEARCH BY THERAPEUTIC AREA, 2013 (%)
CHAPTER 8 MARKET ANALYSIS: CONTRACT PACKAGING
MARKET BY TYPE
MARKET OVERVIEW
MARKET REVENUE
TABLE 44 GLOBAL REVENUE OF CONTRACT PACKAGING BY TYPE, THROUGH 2019 ($ MILLIONS)
FIGURE 33 GLOBAL REVENUE OF CONTRACT PACKAGING BY TYPE, 2012-2019 ($ MILLIONS)
PRIMARY CONTAINERS BY TYPE
TABLE 45 GLOBAL REVENUE OF PRIMARY PACKAGING BY TYPE, THROUGH 2019 ($ MILLIONS)
FIGURE 34 GLOBAL REVENUE OF PRIMARY PACKAGING BY TYPE, 2012-2019 ($ MILLIONS)
MARKET SHARE
TABLE 46 GLOBAL MARKET SHARE OF CONTRACT PACKAGING BY TYPE, 2013 (%)
FIGURE 35 GLOBAL MARKET SHARE OF CONTRACT PACKAGING BY TYPE, 2013 (%)
MARKET BY REGION
MARKET OVERVIEW
MARKET REVENUE
TABLE 47 GLOBAL REVENUE OF CONTRACT PACKAGING BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 36 GLOBAL REVENUE OF CONTRACT PACKAGING BY REGION, 2012-2019 ($ MILLIONS)
MARKET SHARE
TABLE 48 GLOBAL MARKET SHARE OF CONTRACT PACKAGING BY REGION, 2013 (%)
FIGURE 37 GLOBAL MARKET SHARE OF CONTRACT PACKAGING BY REGION, 2013 (%)
PRIMARY PACKAGING BY REGION
TABLE 49 GLOBAL REVENUE FOR PRIMARY PACKAGING BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 38 GLOBAL REVENUE FOR PRIMARY PACKAGING BY REGION, 2012-2019 ($ MILLIONS)
SECONDARY PACKAGING BY REGION
TABLE 50 GLOBAL REVENUE FOR SECONDARY PACKAGING BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 39 GLOBAL REVENUE FOR SECONDARY PACKAGING BY REGION, 2012-2019 ($ MILLIONS)
OTHER TYPES OF PACKAGING BY REGION
TABLE 51 GLOBAL REVENUE FOR OTHER PACKAGING BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 40 GLOBAL REVENUE FOR OTHER PACKAGING BY REGION, 2012-2019 ($ MILLIONS)
CHAPTER 9 INDUSTRY STRUCTURE
CONTRACT MANUFACTURING
MARKET LEADERS
TABLE 52 SERVICES PROVIDED BY CONTRACT MANUFACTURING FIRMS
MARKET SHARES
Bulk Drugs and APIS
TABLE 53 GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/APIs, 2013 (%)
FIGURE 41 GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/APIs, 2013 (%)
Solid-Dosage Forms
TABLE 54 GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2013 (%)
FIGURE 42 GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2013 (%)
Liquid Dosage Forms
Non-sterile
TABLE 55 GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING LIQUID (NON-STERILE) DOSAGE FORMS, 2013 (%)
FIGURE 43 GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING LIQUID (NON-STERILE) DOSAGE FORMS, 2013 (%)
Sterile
TABLE 56 GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING LIQUID (STERILE) DOSAGE FORMS, 2013 (%)
FIGURE 44 GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING LIQUID (STERILE) DOSAGE FORMS, 2013 (%)
Semisolid Dosage Forms
TABLE 57 GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2013 (%)
FIGURE 45 GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2013 (%)
CONTRACT RESEARCH
MARKET LEADERS
TABLE 58 SERVICES PROVIDED BY CONTRACT RESEARCH FIRMS
Market Shares
TABLE 59 GLOBAL MARKET SHARE OF CONTRACT RESEARCH COMPANIES, 2013 (%)
FIGURE 46 GLOBAL MARKET SHARE OF CONTRACT RESEARCH COMPANIES, 2013 (%)
CONTRACT PACKAGING
MARKET LEADERS
TABLE 60 SERVICES PROVIDED BY CONTRACT PACKAGING FIRMS
Market Share
TABLE 61 GLOBAL MARKET SHARE OF CONTRACT PACKAGING COMPANIES, 2013 (%)
FIGURE 47 GLOBAL MARKET SHARE OF CONTRACT PACKAGING COMPANIES, 2013 (%)
CHAPTER 10 PATENT ANALYSIS
PATENTS BY YEAR
TABLE 62 NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2013-JANUARY, 2015
FIGURE 48 NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2013 TO JANUARY 2015
PATENTS BY COMPANY
TABLE 63 NUMBER OF U.S. PATENTS BY COMPANY, JANUARY, 2013-JANUARY, 2015
PATENTS BY COUNTRY
TABLE 64 NUMBER OF U.S. PATENTS BY COUNTRY, 2013-JANUARY, 2015
FIGURE 49 NUMBER OF U.S. PATENTS BY COUNTRY, 2013 TO JANUARY 2015
TABLE 65 PATENT SHARES BY COUNTRY, 2013-JANUARY 2015 (%)
FIGURE 50 PATENT SHARES BY COUNTRY, 2013 TO JANUARY 2015 (%)
PATENTS BY EMPHASIS
TABLE 66 PATENTS BY EMPHASIS, 2013-JANUARY, 2015 (NO. OF ATENTS)
FIGURE 51 PATENTS BY EMPHASIS, 2013 TO JANUARY 2015 (NO. OF PATENTS)
PATENTS BY ASSIGNEE
TABLE 67 NUMBER OF PATENTS BY ASSIGNEE, 2013-JANUARY, 2015
FIGURE 52 NUMBER OF PATENTS BY ASSIGNEE, 2013 TO JANUARY 2015
CHAPTER 11 CURRENT SITUATION
FACTORS AFFECTING THE OUTSOURCING MARKET
COST SAVINGS
DECREASING R&D SUCCESS RATES AND MOUNTING DRUG DEVELOPMENT
COSTS
INCREASING DEMAND FOR BIOSIMILARS
INCREASING BURDEN FROM DISEASE
PATENT CLIFF
TABLE 68 SIGNIFICANT PATENT EXPIRIES OF BIOLOGICS
ACCESS TO CAPABILITIES/STATE-OF-THE-ART TECHNOLOGIES
PHARMACEUTICAL OUTSOURCING TRENDS
CHAPTER 12 COMPANY PROFILES
3M COMPANY
AAIPHARMA SERVICES CORP.
ABBVIE CONTRACT MANUFACTURING
AENOVA HOLDING GMBH
AEROGEN LTD.
AJINOMOTO ALTHEA TECHNOLOGIES INC.
ALBANY MOLECULAR RESEARCH INC. (AMRI)
ALKERMES PLC
AMCOR LTD.
AMERISOURCEBERGEN CORP.
AMPAC FINE CHEMICALS LLC
APTIV SOLUTIONS
APTUIT INC.
ARADIGM CORP.
BAXTER INTERNATIONAL
BCM/BOOTS MANUFACTURING
BOEHRINGER INGELHEIM
CAMBREX CORP.
CANGENE CORPORATION (NOW EMERGENT BIOSOLUTIONS)
CATALENT PHARMA SOLUTIONS
CEDARBURG HAUSER PHARMACEUTICALS INC.
CENEXI
CHARLES RIVER LABORATORIES
CHEMBRIDGE CORP.
CONFAB LABORATORIES
CONTRACT PHARMACEUTICALS LTD.
CORDEN PHARMA SWITZERLAND LLC
COVANCE INC.
deCODE GENETICS
DISHMAN PHARMACEUTICALS AND CHEMICALS LTD.
DPT LABORATORIES INC.
DR. REDDY'S LABORATORIES
DSM PHARMACEUTICAL PRODUCTS INC.
EVOTEC AG
FUJIFILM DIOSYNTH BIOTECHNOLOGY
GIRINDUS AG
GLAXOSMITHKLINE
GRIFOLS INTERNATIONAL S.A.
HERON THERAPEUTICS, INC.
HOSPIRA
HOVIONE S.A
ICON PLC
INC RESEARCH, INC.
JUBILANT LIFE SCIENCES LTD.
KP PHARMACEUTICAL TECHNOLOGY INC.
LIGAND PHARMACEUTICALS, INC.
LONZA GROUP LTD
LYNE LABORATORIES INC.
MALLINCKRODT PHARMACEUTICALS
MEADWESTVACO CORP.
MIKART INC
NEXTPHARMA TECHNOLOGIES
NORWICH PHARMA SERVICES
NOVAVAX, INC.
PACKAGING COORDINATORS INC.
PAREXEL INTERNATIONAL CORP.
PATHEON INC.
PERRIGO COMPANY PLC
PFIZER CENTRESOURCE
PIRAMAL ENTERPRISES LTD.
PPD (PHARMACEUTIAL PRODUCT DEVELOPMENT LLC)
PRA HEALTH SCIENCES
QUINTILES
RANBAXY LABORATORIES LTD.
RECIPHARM AB
REGIS TECHNOLOGIES INC.
SCHOTT PHARMACEUTICAL PACKAGING
SKYEPHARMA PLC
TAKEDA PHARMACEUTICALS
THEOREM CLINICAL RESEARCH INC.
VALEANT PHARMACEUTICALS INTERNATIONAL INC.
VETTER PHARMA INTERNATIONAL GMBH
WOCKHARDT LTD.
WUXI APP TEC
ZACH SYSTEM S.P.A
CHAPTER 13 APPENDIX
ABBREVIATIONS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report